New Technique Could Be a Breakthrough in Multiple Myeloma Treatment

Experts at the OSUCCC – James are working to break new ground in the detection of multiple myeloma.

The research could produce a new technique that could allow for earlier diagnoses of the rare blood cancer, which occurs when plasma cells that normally produce infection-fighting antibodies turn cancerous.

The technique could be a game-changer for multiple myeloma patients by enabling doctors to detect single myeloma cells out of a large number—even a million—other blood cells.

“At The James, we don't just deliver standard of care treatment,” says OSUCCC – James hematologist Srinivas Devarakonda, MD. “We develop treatments that become a new standard of care across the country.”